BAMS
REGN icon

Bellevue Asset Management (Switzerland)’s Regeneron Pharmaceuticals REGN Stock Holding History

Bellevue Asset Management (Switzerland)’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		$19.8M Sell
36,400
-2,500
-6% -$1.35M 3.01% 5
2015
Q3 		$18.1M Buy
38,900
+100
+0.3% +$53.7K 2.95% 5
2015
Q2 		$19.8M Buy
38,800
+10,205
+36% +$4.98M 2.75% 6
2015
Q1 		$12.9M Buy
+28,595
New +$12.1M 1.8% 11

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
LTI
Laffer Tengler Investments Nashville, Tennessee $782M AUM 33.6% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Bellevue Asset Management (Switzerland)'s REGN Position: Q4 2015 in Review

Bellevue Asset Management (Switzerland) reduced its Regeneron Pharmaceuticals (REGN) stake by 6.4% in Q4 2015, selling an estimated $1.35M and leaving 36,400 shares worth $19.8M. The position accounts for 3.01% of the portfolio, ranked #5.

Bellevue Asset Management (Switzerland) first reported a position in REGN in Q1 2015 and has held it in 4 quarters since. The position peaked at $19.8M in Q2 2015. 576 funds tracked by Wall St. Rank hold REGN as of Q4 2015.

  • Bellevue Asset Management (Switzerland) held 36,400 shares of Regeneron Pharmaceuticals worth $19.8M as of Q4 2015.
  • Bellevue Asset Management (Switzerland) sold 2,500 Regeneron Pharmaceuticals shares in Q4 2015, an estimated $1.35M.
  • Regeneron Pharmaceuticals made up 3.01% of Bellevue Asset Management (Switzerland)'s portfolio in Q4 2015, its #5 holding.
  • Bellevue Asset Management (Switzerland) first reported a position in Regeneron Pharmaceuticals in Q1 2015 and has held it in 4 quarters since.
  • Bellevue Asset Management (Switzerland)'s Regeneron Pharmaceuticals position peaked at $19.8M in Q2 2015.
  • 576 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2015.

Based on Bellevue Asset Management (Switzerland)'s 13F filing for Q4 2015, filed 12 Feb 2016.